Cite Filings / KPTI / 0000950170-22-007564
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

Karyopharm Therapeutics Inc. · Filed 2022-05-05 · Acc 0000950170-22-007564

Documents 1

  • 10-Q Quarterly Report , kpti-20220331.htm

Around this filing

  • 2022-08-04 10-Q Quarterly Report
  • 2022-05-09 SC 13G Amended Statement of Ownership
  • 2022-05-05 4 President and CEO sold 28,502 shares at an average $6.23 ($177,509)
  • 2022-05-05 8-K Results of operations
  • 2022-05-05 10-Q Quarterly Report
  • 2022-05-02 4 EVP & Chief Medical Officer acquired 65,000 shares (grant or award)
  • 2021-11-03 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading kpti-20220331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…